For those with hepatitis C, results showed that AST, ALT, and GGT doubled their value from baseline only in one patient, who was receiving etanercept, two other cases presented with increased viral load during their follow-up period, and two patients who were receiving etanercept were diagnosed with hepatocellular carcinoma [65]. The gene discussed is GPT; the disease is hepatocellular carcinoma.